SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 207 filers reported holding SEATTLE GENETICS INC in Q4 2013. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,321,000 | +40.2% | 81,893 | +43.6% | 0.01% | +25.0% |
| Q3 2016 | $3,081,000 | +34.1% | 57,040 | +0.4% | 0.00% | +33.3% |
| Q2 2016 | $2,297,000 | +14.9% | 56,836 | -0.2% | 0.00% | 0.0% |
| Q1 2016 | $1,999,000 | -33.4% | 56,964 | -14.9% | 0.00% | -25.0% |
| Q4 2015 | $3,002,000 | +17.2% | 66,899 | +0.7% | 0.00% | +33.3% |
| Q3 2015 | $2,561,000 | -21.5% | 66,419 | -1.4% | 0.00% | -25.0% |
| Q2 2015 | $3,262,000 | +95.6% | 67,392 | +42.8% | 0.00% | +100.0% |
| Q1 2015 | $1,668,000 | +6.3% | 47,189 | -3.4% | 0.00% | 0.0% |
| Q4 2014 | $1,569,000 | -41.6% | 48,835 | -32.4% | 0.00% | -50.0% |
| Q3 2014 | $2,685,000 | -35.0% | 72,206 | -33.2% | 0.00% | -33.3% |
| Q2 2014 | $4,132,000 | +155.1% | 108,014 | +203.7% | 0.01% | +200.0% |
| Q1 2014 | $1,620,000 | +18.8% | 35,561 | +4.0% | 0.00% | 0.0% |
| Q4 2013 | $1,364,000 | -10.6% | 34,194 | -1.8% | 0.00% | -33.3% |
| Q3 2013 | $1,526,000 | +41.8% | 34,808 | +1.8% | 0.00% | +50.0% |
| Q2 2013 | $1,076,000 | – | 34,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |